Synfacts 2021; 17(10): 1147
DOI: 10.1055/s-0040-1720203
Chemistry in Medicine and Biology

Aziridines Cross-Dimerize to Larger N-Heterocycles

Contributor(s):
Dirk Trauner
,
Tufan K. Mukhopadhyay
Li R, Li B, Zhang H, Ju C.-W, Qin Y, Xue X.-S, Zhao D. * Nankai University, Tianjin, P. R. of China
A Ring Expansion Strategy towards Diverse Azaheterocycles.

Nat. Chem. 2021;
DOI: 10.1038/s41557-021-00746-7.
 

Significance

Azepines, dihydropyridinone, and uracil are key N-heterocyclic motifs found in numerous drug molecules. However, syntheses of these rings often require multistep routes and suffer from poor efficiency. The authors present a robust catalytic method to access these azaheterocycles in an enantiospecific manner via cross-dimerization of aziridines or diaziridinones with cyclopropenones or cyclobutenones. This ring-expansion strategy enabled step-efficient syntheses of several pharmaceutical agents and natural products, underpinning the broader synthetic utility.


#

Comment

Lewis acid-mediated, Pd-catalyzed cross-dimerization of sulfonylated aziridines to benzacyclobutanone afforded the benzazepine skeleton. A synergistic Pd-Cu catalyst system was used to access the pyridinone and uracil motifs from cyclopropenone. A mechanistic study revealed a Pd0/II/IV cycle starting with an oxidative C–C cleavage of the strained carbocycle followed by oxidative aziridine opening to form a PdIV intermediate, which was supported by computational models. This protocol provided concise routes to useful drug precursors (e.g. SKF 38393, GSK 189254, ­ivabradine) with further synthetic modifications of the azepines, rendering this a potential retrosynthetic tool.


#
#

Publication History

Article published online:
17 September 2021

© 2021. Thieme. All rights reserved

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany